We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sol Gel Technologies Ltd | NASDAQ:SLGL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.8504 | 0.7501 | 0.8697 | 0 | 12:00:17 |
H.C. Wainwright 6th Annual Israel Conference
Speaker: | Dr. Alon Seri-Levy, Chief Executive Officer | |
Format: | Corporate Presentation | |
Date: | November 12, 2020 | |
Time: | 8:30 AM ET | |
Jefferies Virtual London Healthcare Conference
Speakers: | Dr. Alon Seri-Levy, Chief Executive Officer | |
Gilad Mamlok, Chief Financial Officer | ||
John Vieira, U.S. Head of Commercialization | ||
Format: | Fireside Chat | |
Date: | November 18, 2020 | |
Time: | 5:00 PM GMT | |
A live webcast of the presentations will be available under the “Events and Presentations” in the investors section of the Company’s website at www.sol-gel.com.
About Sol-Gel TechnologiesSol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Sol-Gel leverages its proprietary microencapsulation technology platform for the development of Twyneo, under investigation for the treatment of acne vulgaris, and Epsolay, under investigation for the treatment of papulopustular rosacea. The Company’s pipeline also includes SGT-210, an early-stage topical epidermal growth factor receptor inhibitor, erlotinib, under investigation for the treatment of palmoplantar keratoderma, and preclinical assets tapinarof and roflumilast. For additional information, please visit www.sol-gel.com.
For further information, please contact:Sol-Gel Contact:Gilad MamlokChief Financial Officer+972-8-9313433
Investor Contact:Lee SternSolebury Trout +1-917-312-5998lstern@soleburytrout.com
Source: Sol-Gel Technologies Ltd.
1 Year Sol Gel Technologies Chart |
1 Month Sol Gel Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions